Back to Companies
ORAMED PHARMACEUTICALS INC.
ORMPNasdaqCIK: 0001176309
Recent Form 4 activity at ORAMED PHARMACEUTICALS INC. (ORMP) spans 22 filings across 7 insiders (all of them on the sell side). Purchases total $0 against $225.5K in sales — heavily weighted toward selling, for net sales of $225.5K. KIDRON NADAV (President and CEO, Director) is the most active by dollar volume, and the single largest transaction was $5.7M by KIDRON NADAV. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$12.5M
Purchases
$0
Sales
$225.5K
Unique Insiders
7
Recent Insider Trades
22 loaded
| Oct 2 | ORMP ORAMED PHARMACEUTICALS INC. | Gabay Avraham | Chief Financial Officer | Sell | $90.2K |
| Oct 2 | ORMP ORAMED PHARMACEUTICALS INC. | Hexter Joshua | COO & CBO | Sell | $135.3K |
| Sep 25 | ORMP ORAMED PHARMACEUTICALS INC. | Kidron Miriam | Chief Scientific Officer, Director | Grant | $3.8M |
| Sep 25 | ORMP ORAMED PHARMACEUTICALS INC. | Hexter Joshua | COO & CBO | Grant | $1.2M |
| Sep 25 | ORMP ORAMED PHARMACEUTICALS INC. | KIDRON NADAV | President and CEO, Director | Grant | $5.7M |
| Sep 25 | ORMP ORAMED PHARMACEUTICALS INC. | Gabay Avraham | Chief Financial Officer | Grant | $0 |
| Mar 31 | ORMP ORAMED PHARMACEUTICALS INC. | KIDRON NADAV | President and CEO, Director | Tax withheld | $148.3K |
| Mar 31 | ORMP ORAMED PHARMACEUTICALS INC. | Kidron Miriam | Chief Scientific Officer, Director | Tax withheld | $1.4M |
| Mar 18 | ORMP ORAMED PHARMACEUTICALS INC. | KIDRON NADAV | President and CEO, Director | Grant | $0 |
| Mar 18 | ORMP ORAMED PHARMACEUTICALS INC. | Gabay Avraham | Chief Financial Officer | Grant | $0 |
| Mar 18 | ORMP ORAMED PHARMACEUTICALS INC. | Hexter Joshua | COO & CBO | Grant | $0 |
| Mar 18 | ORMP ORAMED PHARMACEUTICALS INC. | Kidron Miriam | Chief Scientific Officer, Director | Grant | $0 |
| Jan 29 | ORMP ORAMED PHARMACEUTICALS INC. | Gabay Avraham | Chief Financial Officer | Exercise | $0 |
| Jan 29 | ORMP ORAMED PHARMACEUTICALS INC. | Hexter Joshua | COO & CBO | Exercise | $0 |
| Jan 29 | ORMP ORAMED PHARMACEUTICALS INC. | Kidron Miriam | Chief Scientific Officer, Director | Exercise | $0 |
| Jan 29 | ORMP ORAMED PHARMACEUTICALS INC. | KIDRON NADAV | President and CEO, Director | Exercise | $0 |
| Jan 5 | ORMP ORAMED PHARMACEUTICALS INC. | Hexter Joshua | COO & CBO | Grant | $0 |
| Jan 5 | ORMP ORAMED PHARMACEUTICALS INC. | Reznick Yehuda | Director | Grant | $0 |
| Jan 5 | ORMP ORAMED PHARMACEUTICALS INC. | KIDRON NADAV | President and CEO, Director | Grant | $0 |
| Jan 5 | ORMP ORAMED PHARMACEUTICALS INC. | Mayer Arie | Director | Grant | $0 |
| Jan 5 | ORMP ORAMED PHARMACEUTICALS INC. | Kidron Miriam | Chief Scientific Officer, Director | Grant | $0 |
| Jan 5 | ORMP ORAMED PHARMACEUTICALS INC. | Shapiro Benjamin | Director | Grant | $0 |
22 filings